Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

Six Lessons from Behind the Scenes at City of Hope’s CAR T Cell Program

April 2, 2018 | Wayne Lewis

Often unrecognized are the countless folks who work in the spaces between the lab and the clinic — people responsible for doing everything from manufacturing CAR T cells to gaining federal approval for new trials.

City of Hope's CAR T Work Gets a Boost from TGen

January 30, 2018 | City of Hope

As an affiliate of City of Hope, TGen will use its genomics expertise to chart a path to greater precision in CAR T therapies for cancer patients.

Meet Our CAR T Team: Christine Brown, Ph.D.

January 26, 2018 | Abe Rosenberg

Christine Brown, Ph.D., co-leads the T Cell Therapeutics Research Laboratory, along with Stephen J. Forman, M.D., which to date has treated more than 100 patients in seven clinical trials, with aggressive goals of opening four new clinical studies within the year.

City of Hope researchers find CAR T cell therapy effective in treatment of glioblastoma

July 17, 2017 | Denise Heady

City of Hope researchers have found that using CAR T therapy, a type of immunotherapy, can be effective in the treatment of glioblastoma — one of the most aggressive brain tumors known to medicine.

CAR T cells: ‘Soldiers of the Immune System’

July 10, 2017 | Stephanie Smith

T cells were genetically modified in a lab by City of Hope researchers and trained to target specific receptors on patients’ brain tumors - part of an emerging approach to cancer care called immunotherapy.

World Cancer Day: New treatments and cures start with collaborations

February 3, 2017 | Denise Heady

Defeating cancer cannot be done alone. It requires a team approach. Here are just a few examples of how City of Hope scientists and physicians are working together to create leading-edge approaches to end cancer.

Load More